Caribou Biosciences (CRBU) Capital Expenditures (2020 - 2026)
Caribou Biosciences (CRBU) posted Capital Expenditures of $1,000 for Q2 2026, down 99.8% from $418,000 a year earlier and down 98.6% from the prior quarter.
Caribou Biosciences (CRBU) Capital Expenditures (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Caribou Biosciences was -$28,000; for FY2025, it was $1.36 million, down 72.2% from FY2024.
- Annual Capital Expenditures shows a five-year compound annual growth rate of 33.8% (FY2020 to FY2025).
- In prior years, Caribou Biosciences' Capital Expenditures was $4.88 million in FY2024 (-58.0%), $11.61 million in FY2023 (+79.9%), $6.45 million in FY2022 (+204.3%) and $2.12 million in FY2021 (+569.1%).
- Quarterly Capital Expenditures has run from a low of -$216,000 in Q4 2025 to a high of $4.75 million in Q3 2023 over five years.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q2 2022, with growth of 441.3%; the weakest was Q2 2026, with a decline of 99.8%.
- According to Business Quant data, Capital Expenditures for the three prior quarters was $72,000 (Q1 2026), -$216,000 (Q4 2025) and $115,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Caribou Biosciences | 56.06 Mn | -460.48 Mn | - | 1,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,000.00 |
| Mar 31, 2026 | 72,000.00 |
| Dec 31, 2025 | -216,000.00 |
| Sep 30, 2025 | 115,000.00 |
| Jun 30, 2025 | 418,000.00 |
| Mar 31, 2025 | 1.04 Mn |
| Dec 31, 2024 | 518,000.00 |
| Sep 30, 2024 | 673,000.00 |
| Jun 30, 2024 | 2.24 Mn |
| Mar 31, 2024 | 1.45 Mn |
| Dec 31, 2023 | 2.28 Mn |
| Sep 30, 2023 | 4.75 Mn |
| Jun 30, 2023 | 2.55 Mn |
| Mar 31, 2023 | 2.03 Mn |
| Dec 31, 2022 | 1.76 Mn |
| Sep 30, 2022 | 1.35 Mn |
| Jun 30, 2022 | 2.62 Mn |
| Mar 31, 2022 | 723,000.00 |
| Dec 31, 2021 | 685,000.00 |
| Sep 30, 2021 | 930,000.00 |
Caribou Biosciences Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CRBU&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "CRBU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CRBU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();